Publication | Closed Access

Cost-Effectiveness of Denosumab Compared With Zoledronic Acid in Patients With Breast Cancer and Bone Metastases

Zoledronic AcidDenosumab ComparedOncologyBreast OncologyCancer ManagementOutcomes ResearchBreast CancerCancer TreatmentMedicineRadiation OncologyOsteoporosis